Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF)
1) To evaluate and optimize HeartLogic? Heart Failure Diagnostics (called HeartLogic from here on) clinical integration and the alert management process (Phase I) 2. To evaluate HeartLogic in regards to patient outcomes of death and heart failure hospitalizations (Phase II)
This Study is
No Longer Enrolling
The MANAGE-HF study is a multi-center, global, prospective, open label, multi-phase trial. Phase I will be non-randomized. Phase II will be randomized.
MoreAdult
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Outcomes Research
Memorial Hospital Central
Memorial Hospital North
Protocol Number: 18-6028
More information available at ClinicalTrials.gov: NCT03237858
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers